Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 11575-11576 [2017-03628]
Download as PDF
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
Rachel E. Dickon,
Assistant Secretary.
[FR Doc. 2017–03650 Filed 2–23–17; 8:45 am]
BILLING CODE 6731–AA–P
FEDERAL RESERVE SYSTEM
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than March
8, 2017.
A. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Nancy Eiseman Blackburn, Austin,
Texas; individually, to retain voting
shares of Republic Trinidad
Corporation, Houston, Texas, and
thereby retain shares of The First
National Bank of Trinidad, Trinidad,
Colorado. Notificant will retain shares
individually and part of the Eiseman
Family Group, which controls Republic
Trinidad Corporation.
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
Board of Governors of the Federal Reserve
System, February 21, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–03672 Filed 2–23–17; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than March 17,
2017.
A. Federal Reserve Bank of
Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Glacier Bancorp, Inc., Kalispell,
Montana; to merge with TFB Bancorp,
Inc., Yuma, Arizona, and thereby
acquire The Foothills Bank, Yuma,
Arizona.
B. Federal Reserve Bank of Dallas
(Robert L. Triplett III, Senior Vice
President) 2200 North Pearl Street,
Dallas, Texas 75201–2272:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
1. Vista Bancshares, Inc., Ralls, Texas
and BankCap Equity Fund LLC,
BankCap Partners GP, L.P., and
BankCap Partners Fund I, L.P., all of
Dallas Texas; each a bank holding
company, through BankCap Partners
Opportunity Fund, L.P., Dallas Texas; to
acquire the voting shares of The Hamlin
Financial Corporation, and thereby,
acquire Hamlin National Bank, both of
Hamlin, Texas.
Board of Governors of the Federal Reserve
System, February 21, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017–03671 Filed 2–23–17; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding OpportunityAnnouncements
(FOAs) IP17–002, Improving HPV
Vaccination Coverage among
Adolescent Patients: A Randomized
Controlled Trial of AFIX and Remote
Physician-to-Physician Engagement
Strategies and IP17–003, Rapid-Cycle
Survey Collaborative for Provider Input
on Immunization Issues.
TIME AND DATE: 10:00 a.m.–5:00 p.m.,
EDT, March 15, 2017 (Closed)
PLACE: Teleconference
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
MATTERS FOR DISCUSSION: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Improving HPV Vaccination Coverage
Among Adolescent Patients: A
Randomized Controlled Trial of AFIX
and Remote Physician-to-Physician
E:\FR\FM\24FEN1.SGM
24FEN1
EN24FE17.005
The index percent change for use in
2017 was calculated to be 1.26 and the
Adjusted Cap was calculated to be $30.4
million. The Adjusted Cap rounded to
the nearest $1 million is $30 million.
For 2017 and 2018, the cap for Financial
Responsibility for Indemnification of
Passengers for Nonperformance of
Transportation shall remain at $30
million. The next adjustment will be
conducted in 2019 and will continue to
use $30 million as the Base Cap for
adjustment.
11575
11576
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
Engagement Strategies’’, IP17–002 and
‘‘Rapid-Cycle Survey Collaborative for
Provider Input on Immunization
Issues’’, IP17–003.
CONTACT PERSON FOR MORE INFORMATION:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, Georgia 30333, Telephone:
(404) 718–8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03628 Filed 2–23–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIME AND DATE: 10:00 a.m.–11:30 a.m.,
EDT, March 21, 2017.
PLACE: This meeting will be held by
teleconference.
STATUS: This meeting is open to the
public, limited only by the availability
of telephone ports. The public is
welcome to participate during the
public comment, which is tentatively
scheduled from 11:15 a.m.–11:20 a.m.
EDT. To participate on the
teleconference, please dial (855) 644–
0229 and enter code 1482483.
PURPOSE: The Subcommittee will
provide advice to the CDC Director
through the ACD on strategies, future
needs, and challenges faced by State,
Tribal, Local and Territorial health
agencies, and will provide guidance on
opportunities for CDC.
MATTERS FOR DISCUSSION: The STLT
Subcommittee members will discuss
progress on implementation of ACDadopted recommendations related to the
Jkt 241001
Jose Montero, MD, MPH, Designated
Federal Officer, STLT Subcommittee,
ACD, CDC, 4770 Buford Highway, MS
E70, Atlanta, Georgia 30341, Telephone
(404) 498–0300, Email:
OSTLTSDirector@cdc.gov. Please
submit comments to OSTLTSDirector@
cdc.gov no later than March 17, 2017.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2017–03626 Filed 2–23–17; 8:45 am]
Centers for Disease Control and
Prevention
17:20 Feb 23, 2017
CONTACT PERSON FOR MORE INFORMATION:
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
health department of the future, other
emerging challenges and how CDC can
best support STLT health departments
in the transforming health system.
The agenda is subject to change as
priorities dictate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0733]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Proposed Project
Early Hearing Detection and
Intervention (EHDI) Follow-up Survey
(OMB Control No. 0920–0733,
Expiration Date: 8/31/2016)—
Reinstatement with Change—National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
NCBDDD promotes the health of
babies, children, and adults, with a
focus on preventing birth defects and
developmental disabilities and
optimizing the health outcomes of those
with disabilities. As part of these efforts
NCBDDD is actively involved in
addressing the early identification of
hearing loss among newborns and
infants. Congenital hearing loss is a
common birth defect that affects 1 to 3
per 1,000 live births, or approximately
12,000 children across the United States
annually. Studies have shown that
children with a delayed diagnosis of
hearing loss can experience preventable
delays in speech, language, and
cognitive development. To ensure
children with hearing loss are identified
as soon as possible, many states and
United States (U.S.) territories have
implemented Early Hearing Detection
and Intervention (EHDI) programs and
enacted laws related to infant hearing
screening. The majority of these EHDI
programs have adopted the ‘‘1–3–6’’
plan, which consists of three core goals:
(1) Screening all infants for hearing loss
before 1 month of age, (2) ensuring
diagnostic audiologic evaluation before
3 months of age for those who do not
pass the screening, and (3) enrollment
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11575-11576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03628]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding OpportunityAnnouncements (FOAs)
IP17-002, Improving HPV Vaccination Coverage among Adolescent Patients:
A Randomized Controlled Trial of AFIX and Remote Physician-to-Physician
Engagement Strategies and IP17-003, Rapid-Cycle Survey Collaborative
for Provider Input on Immunization Issues.
TIME AND DATE: 10:00 a.m.-5:00 p.m., EDT, March 15, 2017 (Closed)
PLACE: Teleconference
STATUS: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
MATTERS FOR DISCUSSION: The meeting will include the initial review,
discussion, and evaluation of applications received in response to
``Improving HPV Vaccination Coverage Among Adolescent Patients: A
Randomized Controlled Trial of AFIX and Remote Physician-to-Physician
[[Page 11576]]
Engagement Strategies'', IP17-002 and ``Rapid-Cycle Survey
Collaborative for Provider Input on Immunization Issues'', IP17-003.
CONTACT PERSON FOR MORE INFORMATION: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60,
Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-03628 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P